Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P, ACCENT I Study Group

Open source

DOI: 10.1016/s0140-6736(02)08512-4
Published: 2002 May 4
Container: Lancet (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-02-08512-4,
  title = {Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.},
  author = {Hanauer SB and Feagan BG and Lichtenstein GR and Mayer LF and Schreiber S and Colombel JF and Rachmilewitz D and Wolf DC and Olson A and Bao W and Rutgeerts P and ACCENT I Study Group},
  year = {2002},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(02)08512-4},
  url = {https://doi.org/10.1016/s0140-6736(02)08512-4}
}

RIS

TY  - JOUR
TI  - Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
AU  - Hanauer SB
AU  - Feagan BG
AU  - Lichtenstein GR
AU  - Mayer LF
AU  - Schreiber S
AU  - Colombel JF
AU  - Rachmilewitz D
AU  - Wolf DC
AU  - Olson A
AU  - Bao W
AU  - Rutgeerts P
AU  - ACCENT I Study Group
PY  - 2002
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(02)08512-4
UR  - https://doi.org/10.1016/s0140-6736(02)08512-4
ER  -

APA

SB, H., BG, F., GR, L., LF, M., S, S., JF, C., D, R., DC, W., A, O., W, B., P, R., & Group, A. I. S. (2002). Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(02)08512-4

Source records

pubmed · retrieved 2026-09-26T00:52:51.432Z